Global Electronic Drug Delivery Systems Market - Industry Trends and Forecast To 2027

Report ID: | Publihed: 05-Jan-2020 | No of Pages: 304


USD 3995
USD 5795

Publish Date:


Total pages:


Global electronic drug delivery systems market is projected to register a CAGR of 8.9% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027
Market Segmentation:
Global Electronic Drug Delivery Systems Market, By Type (Electronic Infusion Pumps, Electronic Injection Pens, Electronic Auto-Injectors, Electronic Inhalers, Electronic Capsules, Others), Component (Sensors, Wireless Communicator and Antennas, Micro Pumps and Flow Regulators, Drug Reservoir, Microcontroller, Others), Connectivity (Bluetooth Low Energy (BLE), Wi-Fi, Ethernet, NB-IoT, Others), System Type (Battery-Powered Systems, Rechargeable Systems), Application (Diabetes, Asthma and Chronic Obstructive Pulmonary Disease (COPD), Multiple Sclerosis, Growth Hormone Therapy, Immunodeficiency Disease, Cardiovascular Disease, Thalassemia, Others), End User (Home Healthcare, Hospitals, Clinics, Ambulatory Centers, Others), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Switzerland, Rest Of Europe, Japan, China, South Korea, Australia, India, Singapore, Thailand, Malaysia, Indonesia, Vietnam, Philippines And Rest Of Asia-Pacific, Brazil, Argentina, Peru, Rest Of South America, South Africa, Saudi Arabia, UAE, Egypt, Kuwait, Israel And Rest of Middle East And Africa) Industry Trends and Forecast to 2027

Some of the major factors contributing to the growth of the global electronic drug delivery systems market are:

• Favorable reimbursement scenario
• High prevalence of various chronic disease
Market Players

The key market players for global electronic drug delivery systems market are listed below:

• AstraZeneca
• Amgen Inc.
• Ypsomed AG
• Merck KGaA
• Bayer AG
• Nemera
• F. Hoffmann-La Roche Ltd
• Teva Pharmaceuticals USA, Inc. (A Subsidiary of Teva Pharmaceutical Industries Ltd.)
• AptarGroup, Inc.
• Novo Nordisk A/S
• ViCentra B.V
• Medtronic
• United Therapeutics Corporation
• Companion Medical
• Tandem Diabetes Care
• Debiotech S.A
• Canè SpA
• Insulet Corporation
• BD
• Findair Sp. z o. o
• B. Braun Melsungen AG
• West Pharmaceutical Services, Inc.

Report Subsumes the following

Competitors Analysis Go To Market Strategies
Regional Coverage with precise Market Numbers Global Impact post Covid-19
Market Penetration Strategies Granular breakdown By Type and By Application.